Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $18.2100 (0.05%) ($18.1500 - $19.4800) on Tue. Oct. 1, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 32 | Latest Price | $18.2100(0.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.2% a day on average for past five trading days. | Weekly Trend | IOVA declines -6.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -1.405% in a week (0% probabilities). VIXM(-28%) VXX(-15%) UUP(-9%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
1 - 5 Day Possible Target | $8.35(-54.15%) | Resistance Level | $20.07 | 5 Day Moving Average | $18.29(-0.44%) | 10 Day Moving Average | $19.33(-5.79%) | 20 Day Moving Average | $20.07(-9.27%) | To recent high | -30% | To recent low | 1.2% | Market Cap | $2.667b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |